Name: Latest research reports of Zydus Lifesciences Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Zydus Lifesciences Ltd.
Rating: 5
Author: ICICI Securities Limited

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	15 Jul 2025	Zydus Lifesciences	Consensus Share Price Target	967.65	967.20	-	-0.05	hold	pdf Detailed Estimates
	19 May 2023	Zydus Lifesciences	ICICI Securities Limited Reco Target	967.65	590.00	494.70 (95.60%)	Target met	Buy	pdf post cache	Broker Report US trajectory on a strong footing ICICI Securities Limited Zydus Lifesciences’ (Zydus) Q4FY23 performance was driven by traction in its existing products and exclusive launches such as gRevlimid and gTrokendi XR. Revenue growth and margins of the base business were also quite healthy in our opinion. pdf Copy Link Share on Share on Share on Share on Alert
	18 May 2023	Zydus Lifesciences	Prabhudas Lilladhar Target	967.65	520.00	508.05 (90.46%)	Target met	Accumulate	pdf post cache	Broker Report ZYDUS LIFESCIENCES L Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	18 May 2023	Zydus Lifesciences	Motilal Oswal Target	967.65	550.00	508.05 (90.46%)	Target met	Neutral	pdf post cache	Broker Report LimeRoad integration continues to hurt profitability Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	29 Apr 2023	Zydus Lifesciences	BP Wealth	967.65	597.00	519.90 (86.12%)	Target met	Buy	pdf post cache	Broker Report Zydus Lifesciences Ltd. target price 597 BP Wealth pdf Copy Link Share on Share on Share on Share on Alert
	22 Mar 2023	Zydus Lifesciences	Sharekhan Target	967.65	572.00	478.65 (102.16%)	Target met	Buy	pdf post cache	Broker Report Zydus Life Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	17 Feb 2023	Zydus Lifesciences	Geojit BNP Paribas Reco Target	967.65	528.00	470.65 (105.60%)	Target met	Accumulate	pdf post cache	Broker Report ZYDUS LIFESCIENCES LIMITED Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	06 Feb 2023	Zydus Lifesciences	Prabhudas Lilladhar Target	967.65	480.00	470.15 (105.82%)	Target met	Accumulate	pdf post cache	Broker Report ZYDUS LIFESCIENCES L Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	06 Feb 2023	Zydus Lifesciences	ICICI Securities Limited Target	967.65	482.00	434.65 (122.63%)	Target met	Accumulate	pdf post cache	Broker Report Beats expectations; US launches to support growth ICICI Securities Limited Zydus Lifesciences’ (Zydus) reported Q3FY23 performance exceeded our estimates on all fronts. Revenues grew 19.4% YoY to Rs43.6bn (I-Sec: Rs40.7bn) driven by India and US markets. pdf Copy Link Share on Share on Share on Share on Alert
	04 Feb 2023	Zydus Lifesciences	Motilal Oswal Target	967.65	460.00	434.00 (122.96%)	Target met	Neutral	pdf post cache	Broker Report Strong traction in India/US drives earnings growth Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	04 Feb 2023	Zydus Lifesciences	ICICI Direct Reco Target	967.65	500.00	434.65 (122.63%)	Target met	Buy	pdf post cache	Broker Report Zydus Life Sciences ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
more loading

26.93% Fall from 52W High

Zydus Lifesciences Ltd. share price target

Zydus Lifesciences Ltd. has an average share price target of 988.60. The consensus estimate represents an upside of 2.17% from the last price of 967.65. View 9 reports from 5 analysts offering long-term price targets for Zydus Lifesciences Ltd..

US trajectory on a strong footing

ZYDUS LIFESCIENCES L

LimeRoad integration continues to hurt profitability

Zydus Lifesciences Ltd. target price 597

Zydus Life

ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES L

Beats expectations; US launches to support growth

Strong traction in India/US drives earnings growth

Zydus Life Sciences

Advisor Screeners